Market Value2,381,793,276
Total Holdings60
File Date2023-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
GBT / Global Blood Therapeutics Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
SNDX / Syndax Pharmaceuticals, Inc.
DICE / DICE Therapeutics Inc
IONS / Ionis Pharmaceuticals, Inc.
KALV / KalVista Pharmaceuticals, Inc.
HZNP / Horizon Therapeutics Plc
HZNP / Horizon Therapeutics Plc Put
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) Call
NVCR / NovoCure Limited
FDMT / 4D Molecular Therapeutics, Inc.
RNA / Avidity Biosciences, Inc.
IPSC / Century Therapeutics, Inc.
KURA / Kura Oncology, Inc.
/ Third Harmonic Bio, Inc.
SDGR / Schrödinger, Inc.
BEAM / Beam Therapeutics Inc.
FATE / Fate Therapeutics, Inc.
TCDA / Tricida Inc
MGTA / Magenta Therapeutics Inc
ATXS / Astria Therapeutics, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
PLRX / Pliant Therapeutics, Inc.
ANAB / AnaptysBio, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
VERV / Verve Therapeutics, Inc.
FULC / Fulcrum Therapeutics, Inc.
AUPH / Aurinia Pharmaceuticals Inc.
GHRS / GH Research PLC
BMRN / BioMarin Pharmaceutical Inc.
PASG / Passage Bio, Inc.
ISEE / IVERIC bio Inc Call
ISEE / IVERIC bio Inc
DVAX / Dynavax Technologies Corporation
INSM / Insmed Incorporated
SRPT / Sarepta Therapeutics, Inc.
ETNB / 89bio, Inc.
RETA / Reata Pharmaceuticals Inc - Class A Call
CRNX / Crinetics Pharmaceuticals, Inc.
NKTX / Nkarta, Inc.
JAZZ / Jazz Pharmaceuticals plc
RETA / Reata Pharmaceuticals Inc - Class A Put
BIIB / Biogen Inc.
FMTX / Forma Therapeutics Holdings Inc
KROS / Keros Therapeutics, Inc.
JNCE / Jounce Therapeutics Inc
GRTS / Gritstone bio, Inc.
GERN / Geron Corporation
RPTX / Repare Therapeutics Inc.
NUVB / Nuvation Bio Inc.
ACET / Adicet Bio, Inc.
PTGX / Protagonist Therapeutics, Inc.
ARDX / Ardelyx, Inc.
TCDA / Tricida Inc Call
ALBO / Albireo Pharma Inc
SWTX / SpringWorks Therapeutics, Inc.
VKTX / Viking Therapeutics, Inc.
ABOS / Acumen Pharmaceuticals, Inc.
HOOK / HOOKIPA Pharma Inc.
ASMB / Assembly Biosciences, Inc.
KDNY / Chinook Therapeutics Inc
RLMD / Relmada Therapeutics, Inc.
RLMD / Relmada Therapeutics, Inc. Call
TVTX / Travere Therapeutics, Inc.
ESPR / Esperion Therapeutics, Inc.
VIGL / Vigil Neuroscience, Inc.
AGEN / Agenus Inc.
EWTX / Edgewise Therapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
NTLA / Intellia Therapeutics, Inc.
RAPT / RAPT Therapeutics, Inc.
IMVT / Immunovant, Inc.
AKRO / Akero Therapeutics, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
VRDN / Viridian Therapeutics, Inc.
NRIX / Nurix Therapeutics, Inc.
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
HRTX / Heron Therapeutics, Inc.
ALLK / Allakos Inc.
INZY / Inozyme Pharma, Inc.